A Pilot Study on the Combination Treatment of Reduced-Fluence Photodynamic Therapy, Intravitreal Ranibizumab, Intravitreal Dexamethasone and Oral Minocycline for Neovascular Age-Related Macular Degeneration

Sobha Sivaprasad,S. Patra,J. DaCosta,T. Adewoyin,O. Shona,E. Pearce,N V Chong

A Pilot Study on the Combination Treatment of Reduced-Fluence Photodynamic Therapy, Intravitreal Ranibizumab, Intravitreal Dexamethasone and Oral Minocycline for Neovascular Age-Related Macular Degeneration

2011

Sobha Sivaprasad
S. Patra
J. DaCosta
T. Adewoyin
O. Shona
E. Pearce
N V Chong

Aim: To assess the safety and efficacy of the combined treatment of reduced-fluence verteporfin photodynamic therapy (PDT), intravitreal ranibizumab, intravitreal dexamethasone and

Keywords:

Ranibizumab
Ophthalmology
Macular degeneration
Minocycline
Verteporfin
Dexamethasone
Fluorescein angiography
Combination therapy
Photodynamic therapy
Medicine
Visual acuity
Diabetic retinopathy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations